Muromonab-CD3 FDA Link

Anti-CD3 monoclonal antibody that exerts immunosuppressive effects by inducing peripheral T-cell depletion and modulation of the T-cell receptor complex (CD3/Ti).

Also Known As:

Muromonab CD3; OKT3; Orthoclone OKT3; Monoclonal Antibody OKT3

Pharmalogical Action Categories:

Immunologic Factors
Immunosuppressive Agents

Amino Acids, Peptides, and Proteins: 1
- Proteins: 496323
  - Blood Proteins: 12679
    - Serum Globulins: 555
      - Immunoglobulins: 30911
        Antibodies: 135587
        Monoclonal Antibodies: 57170
        Murine-Derived Monoclonal Antibodies: 1
        Muromonab-CD3: 718
        Immunoglobulin Isotypes: 1094
        Immunoglobulin G: 59781
        Muromonab-CD3: 718
    - Immunoproteins: 43
      - Immunoglobulins: 30911
        Antibodies: 135587
        Monoclonal Antibodies: 57170
        Murine-Derived Monoclonal Antibodies: 1
        Muromonab-CD3: 718
        Immunoglobulin Isotypes: 1094
        Immunoglobulin G: 59781
        Muromonab-CD3: 718
  - Globulins: 3119
    - Serum Globulins: 555
      - Immunoglobulins: 30911
        Antibodies: 135587
        Monoclonal Antibodies: 57170
        Murine-Derived Monoclonal Antibodies: 1
        Muromonab-CD3: 718
        Immunoglobulin Isotypes: 1094
        Immunoglobulin G: 59781
        Muromonab-CD3: 718

Tian-Sheng Lin Selected Research

Tian-Sheng Lin Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure